Firefly Neuroscience Announces Publications Demonstrating the Utility of Advanced EEG Analytics in Drug Development and Neuropsychiatric Care
Growing body of clinical evidence supports use of Company’s FDA-Cleared BNA™ platform to provide objective measures of drug efficacy and cognitive change, driving innovation in brain health Company ...
Firefly Neuroscience announces publications on EEG analytics
Firefly Neuroscience (AIFF) highlights two impactful studies that demonstrate the utility of advanced Resting Electroencephalograms and ...
Nasdaq7d
Firefly Neuroscience, Inc. Advances Neuropharmacology and Psychiatry with Innovative BNA™ Platform Supported by New Clinical Studies
Firefly Neuroscience, Inc. has announced two significant studies supporting its BNA™ platform, which uses advanced EEG technology to enhance drug efficacy evaluations and cognitive assessments ...
Morningstar7d
Firefly Neuroscience Announces Publications Demonstrating the Utility of Advanced EEG Analytics in Drug Development and Neuropsychiatric Care
Growing body of clinical evidence supports use of Company’s FDA-Cleared BNA™ platform to provide objective measures of drug efficacy and cognitive change, driving innovation in brain health ...
Firefly Neuroscience (NASDAQ:AIFF) Stock Price Down 3.9% – What’s Next?
Firefly Neuroscience, Inc. (NASDAQ:AIFF – Get Free Report) traded down 3.9% during mid-day trading on Tuesday . The stock traded as low as $3.43 and last traded at $3.70. 523,068 shares changed hands ...
Mena FN7d
Firefly Neuroscience Announces Publications Demonstrating The Utility Of Advanced EEG Analytics In Drug Development And Neuropsychiatric Care
Firefly Neuroscience, Inc. (“Firefly,” or the“Company”) (NASDAQ: AIFF), an Artificial Intelligence (“AI”) company developing innovative solutions that improve brain health outcomes for ...